MED Institute

What MED Institute does

MED Institute is a medical device contract research organization that provides end-to-end product development services to medical device manufacturers. Founded in 1983 and headquartered in West Lafayette, Indiana, the firm operates as a wholly-owned subsidiary of Cook Group Incorporated, serving clients across 42 medical specialties including orthopedics, biologics, women's health, cardiology, urology, endoscopy, and endovascular technologies. The company employs between 11 and 50 staff, including engineers, scientists, clinical specialists, nurses, and technical personnel, with multi-year contract engagements typical of its enterprise-focused B2B services model.

MED Institute's service portfolio spans nine core lines: medical device engineering (concept development, prototyping, design controls), testing (over 250 accredited tests including durability/fatigue, failure analysis, electrochemical corrosion, particulate matter, and simulative use), regulatory services (FDA/NMPA/PMDA submissions, biological evaluations, toxicology, EUAs), clinical trial services, MRI safety evaluation (ASTM and ISO/TS 10974 methods), computational modeling and simulation, device assembly for early feasibility studies, scientific communications, and pre-clinical testing including in-vivo, in-vitro, cell and gene therapy, and combination product services. The firm's computational modeling and simulation process is qualified as a Medical Device Development Tool (MDDT) by the US FDA — a rare regulatory credential — and the laboratory has maintained ISO/IEC 17025:2017 accreditation through PJLA for 16 years, alongside ISO 13485 certification and ISO 14155 auditing through BSI.

MED Institute generates revenue through fee-for-services project engagements priced via custom quotes. Its go-to-market is primarily enterprise field sales with inbound leads generated through the company website, toll-free and direct phone lines, SEO-optimized technical content, scientific publications, and industry events such as MD&M Minneapolis. The firm collaborates directly with the FDA on research projects (notably MRI RF-induced heating since 2016) and maintains strategic partnerships, including a December 2025 collaboration with Sus Clinicals for preclinical testing. Recent client surveys report satisfaction ratings of 4.98-4.99 out of 5 across 29 responses.

Name

MED Institute

Legal name

MED Institute, Incorporated

Website

https://medinstitute.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

MED Institute is a medical device development services firm providing engineering, testing, regulatory, clinical trial, MRI safety, computational modeling, and preclinical services to medical device manufacturers across 42 medical specialties globally.

Ownership category

akta.pro rank

Headquarters

HQ city

West Lafayette

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Development Services: MED Institute operates as a fee-for-services firm providing comprehensive medical device development services including engineering, testing, regulatory, clinical, and pre-clinical services. Revenue is generated through project-based consulting and service engagements with medical device manufacturers.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

MED Institute is a contract research and development organization that helps medical device manufacturers take products from concept to commercialization. The company delivers integrated engineering, accredited testing (more than 250 ISO/IEC 17025 tests), regulatory affairs, clinical trial, MRI safety, computational modeling and simulation, early-feasibility device assembly, scientific communications, and pre-clinical testing services. Its offerings are designed to be purchased individually or combined, with pricing handled through project-based quotes.

Product overview

MED Institute is a full-service medical device contract research organization (CRO) providing integrated product development services across the entire device lifecycle. The company operates a platform-plus-services model with nine core service lines: Medical Device Engineering (concept development, prototyping, design controls), Medical Device Testing (250+ accredited tests), Regulatory Services (submissions, approvals, biologics evaluations), Clinical Trial Services, MRI Safety, Computational Modeling and Simulation (FDA-qualified MDDT), Device Assembly, Scientific Communications, and Pre-Clinical Testing. These services are designed to work together, enabling clients to move devices from concept through commercialization with a single partner that understands regulatory requirements from early feasibility through post-market surveillance.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Device Engineering Comprehensive engineering services covering the medical device product lifecycle from concept to commercialization, including design controls, validations, risk analysis, and regulatory strategy support for FDA, NMPA, and PMDA submissions; designed for medical device manufacturers.
• Medical Device Testing Portfolio of over 250 accredited tests including durability/fatigue testing, failure analysis, radial force, electrochemical corrosion, particulate matter, simulative use, radiopacity, and non-clinical in-vivo studies; accredited to ISO/IEC 17025:2017 and offered to medical device manufacturers for regulatory submission support.
• Regulatory Services Regulatory affairs services including development process submissions, marketing approvals, post-approval support, biological evaluations, toxicology services, and emergency use authorizations (EUAs); targeted at medical device manufacturers needing FDA, NMPA, PMDA, and EU MDR pathway support.
• Clinical Trial Services Clinical trial planning, data management, project management, monitoring, and clinical site registration services; provides guidance on study design to collect right data cost-effectively for medical device manufacturers and sponsors.
• MRI Safety MRI safety evaluation services including active implantable medical device testing (ISO/TS 10974), RF-induced heating (ASTM F2182), magnetically induced force (ASTM F2052), magnetically induced torque (ASTM F2213), MR image artifacts (ASTM F2119), MRI safety labeling (ASTM F2503), and multiphysics simulation of RF-induced heating; for medical device manufacturers whose devices must be MR-safe.
• Computational Modeling and Simulation (CM&S) Computer-aided engineering using general linear/nonlinear mechanics and fully coupled engineering physics for device design optimization, performance evaluation (fatigue life, MRI RF heating), and design for manufacturing; process qualified as a Medical Device Development Tool (MDDT) through US FDA.
• Device Assembly Early feasibility study (EFS) device assembly services for pre-clinical and early clinical experience, including assembly for permanent implants, delivery systems, and single-use devices under an efficient quality system.
• Scientific Communications Services including clinical evaluation report development and scientific documentation supporting regulatory submissions and CE marking under EU MDR; available to medical device manufacturers needing structured regulatory writing support.
• Pre-Clinical Testing In-vivo studies and in-vitro biological testing including combination product discovery and development (CPDD), cell and gene therapy (CGT) services, drug discovery, and bioanalytical services for medical product manufacturers and sponsors.
• Remediation and Integration Services for addressing quality system deficiencies and integrating processes for medical device manufacturers, often used to remediate quality and regulatory gaps.

Quantifiable outcome

• 4.98-4.99/5 client satisfaction rating

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Sus ClinicalscoreStrategic or Co-development Partner · 11 December 2025MED Institute announced a strategic collaboration with Sus Clinicals to enhance preclinical testing for medical products. The partnership combines expertise in engineering, regulatory strategy, and large animal disease models to accelerate development and improve outcomes for medical product manufacturers.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• NAMSA: NAMSA is the largest medical device-focused contract research organization, offering regulatory, testing, and clinical services to medical device manufacturers. It is the closest functional peer to MED Institute, competing directly across laboratory testing, regulatory strategy, and clinical trial services for medtech clients.
• Nelson Laboratories (Nelson Labs): Nelson Labs is a specialist medical device and pharmaceutical testing laboratory known for biocompatibility, sterilization, and package testing. It directly overlaps MED Institute's accredited medical device testing portfolio and MRI safety/biocompatibility work.
• Eurofins Medical Device Services: Eurofins Medical Device Services offers testing, regulatory, and consulting for medical devices across multiple geographies. It competes with MED Institute in biocompatibility, mechanical testing, and regulatory support for global medtech manufacturers.
• TÜV SÜD (Medical Health Services): TÜV SÜD provides medical device testing, certification, and regulatory services including Notified Body activities for EU MDR/IVDR. It is a direct peer in medical device safety testing and global regulatory pathway services.
• Pacific BioLabs: Pacific BioLabs is a contract testing laboratory providing preclinical, biocompatibility, and medical device testing services in the San Francisco Bay Area. It competes with MED Institute's testing, toxicology, and pre-clinical service lines.
• Toxikon Corporation: Toxikon is a preclinical contract research organization specializing in medical device and pharmaceutical safety, biocompatibility, and toxicology testing. It is a direct peer to MED Institute's toxicology services and pre-clinical testing practice.
• BSI Group (Medical Devices): BSI Group is a Notified Body and standards organization offering medical device certification, regulatory, and compliance services. MED Institute is itself audited by BSI; BSI competes with MED Institute's regulatory services practice and global market access support.
• Element Materials Technology (Medical): Element Materials Technology provides medical device testing including mechanical, fatigue, and biocompatibility testing as part of a global TIC platform. It is a direct testing-services peer to MED Institute's accredited medical device testing portfolio.

Broad incumbents

• WuXi AppTec: WuXi AppTec is one of the largest global CROs offering preclinical, clinical, and bioanalytical services, including for combination products and cell/gene therapy. As a broad incumbent, it overlaps with MED Institute's preclinical and combination product work, though it is far larger and more pharma-leaning.
• Charles River Laboratories: Charles River Laboratories provides preclinical research, safety assessment, and laboratory services. While primarily focused on pharmaceuticals, its preclinical and research services portfolio overlaps with MED Institute's in-vivo and in-vitro testing offerings for medical device manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/med-institute

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MED Institute